Where--and what--are the illnesses accessible to drug therapy in the world?
Kantar Health expands its epidemiology databases to emerging markets, including Turkey and Mexico
Rare Diseases and Orphan Drugs Lift Pharma Innovation
As hundreds of candidate drugs receive official “orphan” status, the Orphan Drug Act gets re-examined. Meanwhile, these drugs are driving the growth of specialty pharmacy
Getting Physician Databases Right
The seemingly routine process of identifying and locating prescribing physicians is becoming a critical industry function
Technology Transfer
How Contract Manufacturers Can Help Pharma Through The Era of Divestiture
Booming Biopharma Cold-Chain Market Attracts High Industry Turnout
Record numbers of attendees and exhibitors came together at Philadelphia meeting
Pharmacos and Payers: Achieving Common Ground in a Changing Market
Emerging Payer Business Trends That Pharmacos Need to Know
Drivers in the post-healthcare-reform world
Approved labeling for tamper-resistant opioid formulations could rest on Web monitoring of drug abusers
The Navippro database, plus some artful online monitoring, could provide outcomes research—of a sort—for drug abuse
Health Reform Includes Research and Prevention
The Rising Importance of Observational Research
International efforts to standardize guidelines for observational research could move the entire field forward
Are Pharma Brands Worth Protecting?
New e-pedigree alliance forms up to address serialization implementation
Group brings together Nosco, Cognex, Acsis and Omega Design, and will support GS1 standards
OM Healthcare Logistics lands first major customer: CareFusion
New 3PL will add a second facility by year-end; stresses the economies of consolidated shipping
Global pharma market will reach $880 billion in 2011, up 5-7%, predicts IMS Health
National illicit-drug use rose by 9% in 2009, say feds
NSDUH survey shows prescription drug abuse rose by 13%, to 7.0 million individuals
ISPE issues a white paper on supply chain security
Advisory panel recommends “signal monitoring” to anticipate potential risks
Thomson Reuters partners with specialist firm to provide API manufacturing-costs estimating
Service will enable first-pass or competitive-intelligence estimating of production costs for active pharmaceutical ingredients based on patent literature
More unit-load devices (ULDs) are now available for cold-chain air freight
Envirotainer and Lufthansa Cargo offer LD9 units for carrying up to four pallets of product
Consumer Survey Highlighting Drug-Safety Worries Accompanies Introduction of
Senator Michael Bennet wants better FDA oversight of drug supply chain and material sourcing, as survey shows that 36% of Americans likely to vote have heard of unsafe ingredients
Medco Will Acquire United BioSource Corp. to Guide Safe and
Acquisition boosts Medco’s ability to develop evidence-based medicine
Reverse Logistics Providers Upgrade Their Service Capabilities
Even while cutting the costs of recalls and returns, providers offer new marketing tools to industry
The Path Ahead for Enterprise Computing
As IT vendors leap into cloud computing, clients in life sciences struggle to keep the data flowing through the organizations
Software as a Service (SaaS) Will Show Robust Growth But Is Not a 'Panacea,' Says Gartner
Research group finds ‘bad practices’ in current implementations as market grows to $8.5 billion
'Shared Services' Organizational Model Has Value for Knowledge-Based Corporate Functions
Deloitte survey finds life sciences companies are consolidating some functions, whether in-house or outsourced
New Company Will Try a Gaming Approach to Medication Adherence
HealthPrize Technologies is readying a sweepstakes approach to encourage patient compliance
The Five Things We Need to Do to Re-invent Commercial Operations
By running Commercial Operations like a stand-alone business, executives can sharpen their focus on strategy, tactics and overall performance
Multi-Channel Marketing Carries Sampling Programs Forward
By combining online with traditional direct-marketing media, manufacturers can accelerate sampling programs even in the face of restricted physician access
Extend Sampling Programs With Telemarketing and Direct Mail
A biopharma marketer uses direct mail and a call center to access hard-to-reach physicians
PDMA 2010: The Power of Sharing
The 2010 PDMA Sharing Conference: Expanding Our Focus With More Learning Opportunities
Living Up to Our Vision
